A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 44 shares of EXEL stock, worth $1,580. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44
Previous 44 -0.0%
Holding current value
$1,580
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$20.34 - $23.73 $122 - $142
6 Added 15.79%
44 $0
Q1 2024

May 06, 2024

SELL
$20.17 - $23.93 $20 - $23
-1 Reduced 2.56%
38 $0
Q4 2023

May 06, 2024

BUY
$19.25 - $24.13 $19 - $24
1 Added 2.63%
39 $936,000
Q4 2023

Feb 05, 2024

BUY
$19.25 - $24.13 $750 - $941
39 New
39 $936,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Di Nuzzo Private Wealth, Inc. Portfolio

Follow Di Nuzzo Private Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Di Nuzzo Private Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Di Nuzzo Private Wealth, Inc. with notifications on news.